Literature DB >> 12812352

Association of interferon-gamma responses to pre-erythrocytic stage vaccine candidate antigens of Plasmodium falciparum in young Kenyan children with improved hemoglobin levels: XV. Asembo Bay Cohort Project.

John M O Ong'echa1, Altaf A Lal, Dianne J Terlouw, Feiko O Ter Kuile, Simon K Kariuki, Venkatchalam Udhayakumar, Alloys S S Orago, Allen W Hightower, Bernard L Nahlen, Ya Ping Shi.   

Abstract

Previous studies in animal models have revealed an association between interferon-gamma (IFN-gamma), produced by CD8+ T cells and irradiated sporozoite-induced sterile immunity. To determine whether IFN-gamma can serve as a marker of pre-erythrocytic protective immunity in individuals naturally exposed to malaria, we characterized IFN-gamma and lymphocyte proliferative responses to previously defined CD8+ cytotoxic T lymphocyte (CTL) epitopes from six pre-erythrocytic stage antigens in 107 children six months to two years old from a community-based birth cohort in western Kenya. We found that IFN-gamma positive responders had higher hemoglobin (Hb) levels and significantly reduced prevalence of severe malarial anemia one month after the test compared with IFN-gamma non-responders, suggesting that IFN-gamma immune responses to these pre-erythrocytic antigens were associated with protection against malarial anemia. Children who responded by lymphocyte proliferation had a significantly longer time to first documented malaria parasitemia after birth; however, there was no correlation between the presence of lymphocyte proliferative response and higher Hb levels. We propose that IFN-gamma production could be used as a potential marker of protective immunity against malaria associated anemia in young children living in malaria holoendemic areas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12812352     DOI: 10.4269/ajtmh.2003.68.590

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Authors:  Lyticia A Ochola; Cyrus Ayieko; Lily Kisia; Ng'wena G Magak; Estela Shabani; Collins Ouma; Chandy C John
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

2.  Pro- and anti-inflammatory cytokines in children with malaria in Franceville, Gabon.

Authors:  Sandrine Lydie Oyegue-Liabagui; Aline Gaëlle Bouopda-Tuedom; Lady Charlène Kouna; Sydney Maghendji-Nzondo; Herman Nzoughe; Nina Tchitoula-Makaya; Irene Pegha-Moukandja; Jean-Bernard Lekana-Douki
Journal:  Am J Clin Exp Immunol       Date:  2017-02-15

3.  Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.

Authors:  John M Ong'echa; Gregory C Davenport; John M Vulule; James B Hittner; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

Review 4.  Immune Responses in Malaria.

Authors:  Carole A Long; Fidel Zavala
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

5.  Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.

Authors:  Chandy C John; Ann M Moormann; Peter O Sumba; Ayub V Ofulla; Daniel C Pregibon; James W Kazura
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya.

Authors:  Ann M Moormann; Peter Odada Sumba; Daniel J Tisch; Paula Embury; Charles H King; James W Kazura; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

Review 7.  Severe malarial anemia: innate immunity and pathogenesis.

Authors:  Douglas J Perkins; Tom Were; Gregory C Davenport; Prakasha Kempaiah; James B Hittner; John Michael Ong'echa
Journal:  Int J Biol Sci       Date:  2011-11-02       Impact factor: 6.580

8.  A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.

Authors:  Vasee S Moorthy; Egeruan B Imoukhuede; Paul Milligan; Kalifa Bojang; Sheila Keating; Pauline Kaye; Margaret Pinder; Sarah C Gilbert; Gijs Walraven; Brian M Greenwood; Adrian S V Hill
Journal:  PLoS Med       Date:  2004-10-26       Impact factor: 11.069

Review 9.  Interferon-γ: The Jekyll and Hyde of Malaria.

Authors:  Thayer King; Tracey Lamb
Journal:  PLoS Pathog       Date:  2015-10-01       Impact factor: 6.823

10.  Interferon-gamma responses to Plasmodium falciparum liver-stage antigen-1 and merozoite-surface protein-1 increase with age in children in a malaria holoendemic area of western Kenya.

Authors:  Kiprotich Chelimo; Peter O Sumba; James W Kazura; Ayub V Ofula; Chandy C John
Journal:  Malar J       Date:  2003-11-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.